Ethnopharmacological relevance and anti-tuberculosis potential of selected Zingiber species: a critical evaluation of the evidence

Tuberculosis (TB) remains a major global health problem, particularly with the continued emergence of drug-resistant Mycobacterium tuberculosis . Indonesia combines a high TB burden with extensive biodiversity and a long tradition of medicinal plant use, providing an important setting for ethnopharmacology-guided natural product research. Several Zingiber species used in Indonesian traditional medicine share respiratory-related indications, while more limited reports specifically describe their use for tuberculosis. This review critically evaluates the extent to which these ethnopharmacological observations are supported by experimental evidence relevant to TB and examines whether selected Zingiber taxa or their metabolites warrant further investigation as potential adjuncts to anti-TB therapy. Direct antimycobacterial activity has been reported for selected Zingiber preparations and metabolites, but the evidence varies substantially across mycobacterial models and study quality. Some preparations showed notable in vitro activity, whereas others were active only at high concentrations, and selectivity was frequently not assessed. Among individual metabolites, 6-gingerol has the broadest TB-specific experimental support, including drug-resistant isolates and in vivo infection models, although its reported potency varies across studies. Evidence for an adjunctive role is sparse. Selected metabolites have been reported to modify responses to anti-TB drugs, and 6-gingerol has been shown to reduce energy-dependent efflux in Staphylococcus aureus; however, direct evidence for efflux, resistance or drug-tolerance modulation in M. tuberculosis remains lacking. Pharmacokinetic interaction and unfavorable in vitro selectivity have also been reported for selected metabolites. Overall, the available evidence provides preliminary support for the anti-TB potential of selected Zingiber taxa and their metabolites, but remains too limited and heterogeneous to draw firm conclusions. An adjunctive role remains a hypothesis requiring further investigation, and its relevance to drug-resistant TB remains uncertain. Further studies using well-characterized botanical materials, clinically relevant mycobacterial models, selectivity assessment, and direct anti-TB drug-interaction studies are needed to determine their translational relevance.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-19
DOI
https://doi.org/10.3389/fphar.2026.1976528
Primary Topic
Ginger and Zingiberaceae research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Ethnopharmacological relevance and anti-tuberculosis potential of selected Zingiber species: a critical evaluation of the evidence

D. A. E. Pitaloka, Y. Yuliandra, S. Bhakta, N. F. Kurniati et al.
Frontiers in Pharmacology
Ginger and Zingiberaceae research
article

Ethnopharmacological relevance and anti-tuberculosis potential of selected Zingiber species: a critical evaluation of the evidence

D. A. E. Pitaloka, Y. Yuliandra, S. Bhakta, N. F. Kurniati, A. S. Sinulingga, R. A. Edrada-Ebel
article en

Abstract

Tuberculosis (TB) remains a major global health problem, particularly with the continued emergence of drug-resistant Mycobacterium tuberculosis . Indonesia combines a high TB burden with extensive biodiversity and a long tradition of medicinal plant use, providing an important setting for ethnopharmacology-guided natural product research. Several Zingiber species used in Indonesian traditional medicine share respiratory-related indications, while more limited reports specifically describe their use for tuberculosis. This review critically evaluates the extent to which these ethnopharmacological observations are supported by experimental evidence relevant to TB and examines whether selected Zingiber taxa or their metabolites warrant further investigation as potential adjuncts to anti-TB therapy. Direct antimycobacterial activity has been reported for selected Zingiber preparations and metabolites, but the evidence varies substantially across mycobacterial models and study quality. Some preparations showed notable in vitro activity, whereas others were active only at high concentrations, and selectivity was frequently not assessed. Among individual metabolites, 6-gingerol has the broadest TB-specific experimental support, including drug-resistant isolates and in vivo infection models, although its reported potency varies across studies. Evidence for an adjunctive role is sparse. Selected metabolites have been reported to modify responses to anti-TB drugs, and 6-gingerol has been shown to reduce energy-dependent efflux in Staphylococcus aureus; however, direct evidence for efflux, resistance or drug-tolerance modulation in M. tuberculosis remains lacking. Pharmacokinetic interaction and unfavorable in vitro selectivity have also been reported for selected metabolites. Overall, the available evidence provides preliminary support for the anti-TB potential of selected Zingiber taxa and their metabolites, but remains too limited and heterogeneous to draw firm conclusions. An adjunctive role remains a hypothesis requiring further investigation, and its relevance to drug-resistant TB remains uncertain. Further studies using well-characterized botanical materials, clinically relevant mycobacterial models, selectivity assessment, and direct anti-TB drug-interaction studies are needed to determine their translational relevance.

Frontiers in PharmacologyVol. 17
Bandung Institute of Technology (ID), University of Strathclyde (GB), Institute of Structural and Molecular Biology (GB), Universitas Teknologi Bandung (ID), Andalas University (ID), Padjadjaran University (ID), Birkbeck, University of London (GB)
Ginger and Zingiberaceae research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon